NOTCH1, HIF1A and Other Cancer-Related Proteins in Lung Tissue from Uranium Miners-Variation by Occupational Exposure and Subtype of Lung Cancer

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Pesch, Beate ^a   Casjens, Swaantje ^a   Stricker, Ingo ^a   Westerwick, Daniela ^a   Taeger, Dirk ^a   Rabstein, Sylvia ^a   Wiethege, Thorsten ^a   Tannapfel, Andrea ^a   Brüning, Thomas ^a   Johnen, Georg ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MUCIN 1; NOTCH1 RECEPTOR; RADON; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.1; UNCLASSIFIED DRUG; URANIUM;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIFESPAN; LONG TERM EXPOSURE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL EXPOSURE; UPREGULATION; URANIUM MINE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MINING; OCCUPATIONAL EXPOSURE; RECEPTOR, NOTCH1; SMALL CELL LUNG CARCINOMA; URANIUM;

EID: 84866456551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045305     Document Type: Article

References (51)

1. Schroder C, Friedrich K, Butz M, Koppisch D, Otten H, (2002) Uranium mining in Germany: incidence of occupational diseases 1946-1999. Int Arch Occup Environ Health 75: 235-242.
2. Lehmann F, Hambeck F, Linkert KH, Lutze H, Meyer H, et al. (1998) Belastung durch ionisierende Strahlung im Uranerzbergbau der ehemaligen DDR: Abschlussbericht zu einem Forschungsvorhaben. Hauptverband der gewerblichen Berufsgenossenschaften (HVBG), Sankt Augustin, Germany.
3. Dahmann D, Bauer HD, Stoyke G, (2008) Retrospective exposure assessment for respirable and inhalable dust, crystalline silica and arsenic in the former German uranium mines of SAG/SDAG Wismut. Int Arch Occup Environ Health 81: 949-958.
4. Kreuzer M, Walsh L, Schnelzer M, Tschense A, Grosche B, (2008) Radon and risk of extrapulmonary cancers: results of the German uranium miners' cohort study, 1960-2003. British Journal of Cancer 99: 1946-1953.
5. Walsh L, Tschense A, Schnelzer M, Dufey F, Grosche B, et al. (2010) The influence of radon exposures on lung cancer mortality in German uranium miners, 1946-2003. Radiat Res 173: 79-90.
6. Ruano-Ravina A, Faraldo-Valles MJ, Barros-Dios JM, (2009) Is there a specific mutation of p53 gene due to radon exposure? A systematic review. Int J Radiat Biol 85: 614-621.
7. Detours V, Delys L, Libert F, Weiss SD, Bogdanova T, et al. (2007) Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 97: 818-825.
8. Detours V, Versteyhe S, Dumont JE, Maenhaut C, (2008) Gene expression profiles of post-Chernobyl thyroid cancers. Curr Opin Endocrinol Diabetes Obes 15: 440-445.
9. Tsuji H, Ishii-Ohba H, Ukai H, Katsube T, Ogiu T, (2003) Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. Carcinogenesis 24: 1257-1268.
10. Kahn P, (1993) A Grisly Archive of Key Cancer Data. Science 259: 448-451.
11. Taeger D, Johnen G, Wiethege T, Tapio S, Möhner M, et al. (2009) Major histopathological patterns of lung cancer related to arsenic exposure in German uranium miners. Int Arch Occup Environ Health 82: 867-875.
12. Taeger D, Fritsch A, Wiethege T, Johnen G, Eisenmenger A, et al. (2006) Role of exposure to radon and silicosis on the cell type of lung carcinoma in German uranium miners. Cancer 106: 881-889.
13. Pesch B, Kendzia B, Gustavsson P, Jockel KH, Johnen G, et al. (2011) Cigarette smoking and lung cancer- relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer doi: 10.1002/ijc.2733910.1002/ijc.27339. In press.
14. Wesch H, Eisenmenger A, Mueller KM, Wiethege Th (2005) Radiologische Erfassung, Untersuchung und Bewertung bergbaulicher Altlasten- Gesundheitliche Bewertung- Teilprojekt Pathologie Schriftenreihe: Reaktorsicherheit und Strahlenschutz Bundesministerium für Umwelt,Naturschutz und Reaktorsicherheit, Bonn, Germany; BMU- 2005-652 and ISSN 1612-6386.
15. Travis WD, Colby TV, Corrin B, Shimosato Y, and collaborators from 14 countries (1999) Histological typing of lung and pleural tumors. Berlin: World Health Organisation, Springer. 156 p.
16. Wiethege T, Wesch H, Wegener K, Muller KM, Mehlhorn J, et al. (1999) German uranium miner study-pathological and molecular genetic findings. German Uranium Miner Study, Research Group Pathology. Radiat Res 152: S52-S55.
17. NIOSH (2000) Study of the feasibility of research on pathologic types of lung cancer in silica- and radon-exposed miners- final report. PB20001101410 National Institute for Occupational Safety and Health, Morgantown.
18. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
19. Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
20. Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, et al. (2010) Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9: 180.
21. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, et al. (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28: 17-28.
22. Bailey KA, Hester SD, Knapp GW, Owen RD, Thai SF, (2010) Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals. Mol Carcinog 49: 981-998.
23. Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM, (2006) Airway mucus: From production to secretion. Am J Respir Cell Mol Biol 34: 527-536.
24. Kim YS, Ho SB, (2010) Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 12: 319-330.
25. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, et al. (2008) The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 3: 1468-1481.
26. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang LQ, et al. (2003) Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163: 1949-1960.
27. Liu H, Kho AT, Kohane IS, Sun Y, (2006) Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med 3: e232.
28. Wang GL, Jiang BH, Rue EA, Semenza GL, (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514.
29. Luo W, Semenza GL, (2011) Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2: 551-556.
30. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW, (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36: 1-12.
31. Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, et al. (2009) Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer. J Thorac Oncol 4: 284-290.
32. Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, et al. (2007) Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 25: 5562-5569.
33. Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, et al. (2009) Prognostic gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci U S A 106: 2824-2828.
34. Semenza GL, (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
35. Semenza GL, (2009) HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr Pharm Des 15: 3839-3843.
36. Weir BA, Woo MS, Getz G, Perner S, Ding L, (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
37. Maeda Y, Dave V, Whitsett JA, (2007) Transcriptional control of lung morphogenesis. Physiol Rev 87: 219-244.
38. Rose MC, Voynow JA, (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86: 245-278.
39. Charloux A, Quoix E, Wolkove N, Small D, Pauli G, et al. (1997) The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 26: 14-23.
40. Blair A, Stewart P, Lubin JH, Forastiere F, (2007) Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med 50: 199-207.
41. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16: 430-441.
42. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, et al. (2005) Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer 92: 1545-1552.
43. Ahmed FE, (2009) Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. J Sep Sci 32: 771-798.
44. Cheung W, Darfler MM, Alvarez H, Hood BL, Conrads TP, et al. (2008) Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology 8: 608-616.
45. Rawlins EL, Ostrowski LE, Randell SH, Hogan BL, (2007) Lung development and repair: contribution of the ciliated lineage. Proc Natl Acad Sci U S A 104: 410-417.
46. Rawlins EL, (2008) Lung epithelial progenitor cells: lessons from development. Proc Am Thorac Soc 5: 675-681.
47. Daniel VC, Peacock CD, Watkins DN, (2006) Developmental signalling pathways in lung cancer. Respirology 11: 234-240.
48. Lam WK, Watkins DN, (2007) Lung cancer: future directions. Respirology 12: 471-477.
49. Warburton D, Perin L, Defilippo R, Bellusci S, Shi W, et al. (2008) Stem/progenitor cells in lung development, injury repair, and regeneration. Proc Am Thorac Soc 5: 703-706.
50. Zochbauer-Muller S, Gazdar AF, Minna JD, (2002) Molecular pathogenesis of lung cancer. Annu Rev Physiol 64: 681-708.
51. Liu X, Engelhardt JF, (2008) The glandular stem/progenitor cell niche in airway development and repair. Proc Am Thorac Soc 5: 682-688.